Organ Care System (OCS™) Lung System

Normothermic Machine Perfusion System For The Preservation Of Standard Criteria Donor Lungs Prior To Transplantation

FDA Premarket Approval P160013

This medical device has supplements. The device description/function or indication may have changed. Be sure to look at the supplements to get an up-to-date information on device changes. The labeling included below is the version at time of approval of the original pma or panel track supplement and may not represent the most recent labeling.

Pre-market Approval Supplement Details

Approval for the ocs lung system, indicated for the preservation of standard criteria donor lungs in a near physiologic, ventilated, and perfused state for double lung transplantation.

DeviceOrgan Care System (OCS™) Lung System
Classification NameNormothermic Machine Perfusion System For The Preservation Of Standard Criteria Donor Lungs Prior To Transplantation
Generic NameNormothermic Machine Perfusion System For The Preservation Of Standard Criteria Donor Lungs Prior To Transplantation
ApplicantTransMedics, Inc
Date Received2016-04-28
Decision Date2018-03-22
Notice Date2018-04-10
PMAP160013
SupplementS
Product CodeQBA
Docket Number18M-1237
Advisory CommitteeGastroenterology/Urology
Expedited ReviewYes
Combination Product No
Applicant Address TransMedics, Inc 200 Minuteman Road suite 302 andover, MA 01810
Summary:Summary of Safety and Effectiveness
Labeling: Labeling Labeling Part 2
Post-Approval Study:Show Report Schedule and Study Progress
Approval Order: Approval Order

Supplemental Filings

Supplement NumberDateSupplement Type
P160013Original Filing
S009 2022-02-07 Real-time Process
S008 2021-05-04 Real-time Process
S007 2020-09-04 Real-time Process
S006 2019-09-23 Real-time Process
S005 2019-09-23 Real-time Process
S004
S003 2018-09-27 Real-time Process
S002
S001 2018-04-06 Normal 180 Day Track No User Fee

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.